Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,993,920
-$1,500,046 QoQ
Shares Held
82,804
-33.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#965
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JACOBS & CO/CA holds $94,475,102 across 9 Drug Manufacturers - General names. PFE ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,017 | $34,803,863 | |
| 2 | ABBV |
AbbVie Inc.
|
61,621 | $15,506,308 | |
| 3 | AMGN |
Amgen Inc
|
42,343 | $15,333,247 | |
| 4 | MRK |
Merck & Co., Inc.
|
103,952 | $13,357,832 | |
| 5 | JNJ |
Johnson & Johnson
|
48,675 | $12,361,989 | |
| 6 | PFE |
Pfizer Inc
This page
|
82,804 | $1,993,920 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,090 | $516,730 | |
| 8 | NVS |
Novartis AG
|
2,520 | $394,934 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,993,920 | 82,804 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,493,966 | 124,429 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $3,871,950 | 155,500 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $4,677,261 | 183,566 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $4,668,163 | 192,581 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $5,798,856 | 228,842 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $6,314,723 | 238,022 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $8,345,196 | 288,362 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $8,994,450 | 321,460 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $9,359,603 | 337,283 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $9,501,362 | 330,023 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $10,774,710 | 324,833 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $11,651,768 | 317,660 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $13,237,723 | 324,454 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $16,426,467 | 320,579 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $14,023,110 | 320,455 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $16,363,560 | 312,103 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $16,227,099 | 313,446 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $18,766,267 | 317,803 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $13,620,234 | 316,676 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $12,055,484 | 307,852 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $10,920,374 | 301,418 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $10,360,100 | 281,448 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $10,028,081 | 273,245 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $6,659,623 | 203,658 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $5,796,758 | 177,597 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||